{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:09Z","timestamp":1753891029698,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The role of N6-methyladenosine (m6A) modification in tumor microenvironment has rarely been explored in follicular lymphoma (FL). To examine the role of m6A modification in biological behavior, especially the immune landscape of FL, we utilized the Gene Expression Omnibus database to determine the expression signatures of m6A-regulators by unsupervised clustering, and then condense into a risk score, which was validated in an external cohort from the Tianjin Medical University Cancer Institute and Hospital. Finally, 16 m6A-regulators in 351 FL patients were evaluated and two m6A clusters were identified, characterized by differences in prognosis and biological behaviors. The m6A score was further developed based on 20-genes to quantify the m6A-regulator expression signature in each patient with FL. The low m6A score was associated with inferior prognosis of patients, with a median survival time of 8.84 (95% confidence interval [CI]: 7.251-10.429) years, which was remarkably shorter than that of patients with high m6A scores (15.73 years, 95% CI: 11.729-19.731; p&amp;lt;0.0001). Genes like TNFRSF14, CREBBP, and CARD11 were shown to be more often mutated in the low m6A group. This group was enriched with immune\/inflammatory response but along with the abundant infiltration of exhausted T cells and the upregulated PD-1 and PD-L1 expression. Finally, we verified the m6A score could predict the response to anti-PD-L1 antibodies in an immunotherapy cohort. To conclude, the m6A score recognizes a section of FL patients harboring an exhausted tumor microenvironment and may help guide more effective immunotherapy strategies for patients with FL.<\/jats:p>","DOI":"10.3389\/fimmu.2022.922471","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T09:33:17Z","timestamp":1654507997000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment"],"prefix":"10.3389","volume":"13","author":[{"given":"Tingting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengzi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7497\/j.issn.2095-3941.2013.01.006","article-title":"Guidelines for the Diagnosis and Treatment of Follicular Lymphoma in China","volume":"10","year":"2013","journal-title":"Cancer Biol Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study","volume":"33","author":"Casulo","year":"2015","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.1664.1664","article-title":"Event-Free Survival at 12 Months (EFS12) From Diagnosis Is a Robust Endpoint for Disease-Related Survival in Patients With Follicular Lymphoma in the Immunochemotherapy Era","volume":"124","author":"Maurer","year":"2014","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1182\/blood-2017-08-737361","article-title":"Chromatin Modifying Gene Mutations in Follicular Lymphoma","volume":"131","author":"Green","year":"2018","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.127","article-title":"From Genetics to the Clinic: A Translational Perspective on Follicular Lymphoma","volume":"18","author":"Huet","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.005","article-title":"Emerging Roles of RNA Modification: M(6)A and U-Tail","volume":"158","author":"Lee","year":"2014","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature12730","article-title":"N6-Methyladenosine-Dependent Regulation of Messenger RNA Stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-Methyladenosine Modulates Messenger RNA Translation Efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear M(6)A Reader YTHDC1 Regulates mRNA Splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 Mediates Nuclear Export of N(6)-Methyladenosine Methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"Elife"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25967","article-title":"Regulatory Role of N(6) -Methyladenosine (M(6) A) Methylation in RNA Processing and Human Diseases","volume":"118","author":"Wei","year":"2017","journal-title":"J Cell Biochem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4416","article-title":"The N(6)-Methyladenosine (M(6)A)-Forming Enzyme METTL3 Controls Myeloid Differentiation of Normal Hematopoietic and Leukemia Cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 Inhibits Hematopoietic Stem\/Progenitor Differentiation and Promotes Leukemogenesis via mRNA M(6)A Modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature24678","article-title":"Promoter-Bound METTL3 Maintains Myeloid Leukaemia by M(6)A-Dependent Translation Control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2410","article-title":"M6a Methyltransferase Wilms' Tumor 1-Associated Protein Facilitates Cell Proliferation and Cisplatin Resistance in NK\/T Cell Lymphoma by Regulating Dual-Specificity Phosphatases 6 Expression via M6a RNA Methylation","volume":"73","author":"Ma","year":"2021","journal-title":"IUBMB Life"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00955","article-title":"The M6a Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating M6a Modification in PEDF","volume":"11","author":"Cheng","year":"2020","journal-title":"Front Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0650-4","article-title":"The RNA Modification N(6)-Methyladenosine as a Novel Regulator of the Immune System","volume":"21","author":"Shulman","year":"2020","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6327614","DOI":"10.1155\/2020\/6327614","article-title":"RNA N(6)-Methyladenosine Modifications and the Immune Response","volume":"2020","author":"Wang","year":"2020","journal-title":"J Immunol Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","article-title":"M(6)A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Gastric Cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001646","article-title":"M(6)A Modification Patterns and Tumor Immune Landscape in Clear Cell Renal Carcinoma","volume":"9","author":"Zhong","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0168-5","article-title":"Writing and Erasing mRNA Methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting Batch Effects in Microarray Expression Data Using Empirical Bayes Methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: A Class Discovery Tool With Confidence Assessments and Item Tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene Set Variation Analysis for Microarray and RNA-Seq Data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-Responsive Genes Involved in Oxidative Phosphorylation Are Coordinately Downregulated in Human Diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp698","article-title":"And Accurate Long-Read Alignment With Burrows-Wheeler Transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve Years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: A MapReduce Framework for Analyzing Next-Generation DNA Sequencing Data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: Functional Annotation of Genetic Variants From High-Throughput Sequencing Data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the Population Abundance of Tissue-Infiltrating Immune and Stromal Cell Populations Using Gene Expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","article-title":"ImmuCellAI: A Unique Method for Comprehensive T-Cell Subsets Abundance Prediction and Its Application in Cancer Immunotherapy","volume":"7","author":"Miao","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"Tgf\u03b2 Attenuates Tumour Response to PD-L1 Blockade by Contributing to Exclusion of T Cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T Cell Dysfunction and Exclusion Predict Cancer Immunotherapy Response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91190","article-title":"IFN-Gamma-Related mRNA Profile Predicts Clinical Response to PD-1 Blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3622","article-title":"CBP\/p300 Drives the Differentiation of Regulatory T Cells Through Transcriptional and Non-Transcriptional Mechanisms","volume":"79","author":"Castillo","year":"2019","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nri1917","article-title":"Balancing Co-Stimulation and Inhibition With BTLA and HVEM","volume":"6","author":"Murphy","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and Cellular Insights Into T Cell Exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.101","article-title":"IFN-\u03b3 From Lymphocytes Induces PD-L1 Expression and Promotes Progression of Ovarian Cancer","volume":"112","author":"Abiko","year":"2015","journal-title":"Br J Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the Tumor Immune Microenvironment (TIME) for Effective Therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to Treat Immune Hot, Altered and Cold Tumours With Combination Immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-3-319-67577-0_2","article-title":"Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment","volume":"1036","author":"Gajewski","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-Tumour Immunity Controlled Through mRNA M(6)A Methylation and YTHDF1 in Dendritic Cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.6b00023","article-title":"A Novel Inhibitor of the Obesity-Related Protein FTO","volume":"55","author":"Qiao","year":"2016","journal-title":"Biochemistry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.550350","article-title":"Structures of Human ALKBH5 Demethylase Reveal a Unique Binding Mode for Specific Single-Stranded N6-Methyladenosine RNA Demethylation","volume":"289","author":"Xu","year":"2014","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1021\/ja3064149","article-title":"Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor","volume":"134","author":"Chen","year":"2012","journal-title":"J Am Chem Soc"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.922471\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T09:33:21Z","timestamp":1654508001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.922471\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2022.922471"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.922471","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"article-number":"922471"}}